Executive functions, mental health, and quality of life in healthy older adults [0.03%]
执行功能，心理健康与健康老年人的生活质量
Cássia Elisa Rossetto Verga,Gabriela Dos Santos,Tiago Nascimento Ordonez et al.
Cássia Elisa Rossetto Verga et al.
Population aging brings about numerous challenges, particularly concerning cognitive health. In this context, socioeconomic factors such as education have received special attention due to their role in brain health. ...
Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology [0.03%]
巴西阿尔茨海默病患者使用抗淀粉样蛋白药物的治疗立场文件——来自巴西神经科学会认知神经学和老年学会员部门的声明论文
Breno José Alencar Pires Barbosa,Elisa de Paula França Resende,Raphael Machado Castilhos et al.
Breno José Alencar Pires Barbosa et al.
Novel therapies for Alzheimer's disease, particularly anti-amyloid drugs like lecanemab and donanemab, have shown modest clinical benefits but also significant risks. The present paper highlights the challenges of access to diagnosis, cost-...
Brain morphometry in transient global amnesia: a triangulated analysis approach [0.03%]
三角测量分析方法在短暂性全面遗忘症脑形态学中的应用研究
Micaela Anahi Hernández,Hernán Chaves,Ricardo Francisco Allegri et al.
Micaela Anahi Hernández et al.
Transient global amnesia (TGA) is a rare, temporary, sudden-onset disturbance in anterograde episodic memory with unclear pathophysiology. Previous brain volumetric analysis in TGA patients showed varied results. ...
Caring for people with dementia during the COVID-19 pandemic:a systematic review [0.03%]
2019冠状病毒病大流行期间的痴呆患者护理：系统评价研究
Juan Jesús Robles-García,José Ángel Martínez-López
Juan Jesús Robles-García
Human history has been linked to numerous risks to survival, with pandemics being a constant in human life. People suffering from dementia experienced greater difficulties accessing healthcare and treatment during the COVID-19 pandemic. ...
Laura Beatriz Dias Estrada,Wyllians Vendramini Borelli,Helen Bedinoto Durgante
Laura Beatriz Dias Estrada
To date, little is known about psychological and personality variables related to protective factors against the development of dementia. The Five-Factor Model of personality is worldwide recognized and consolidated for understanding the st...
Challenges in evaluating cognitive impairment in diabetics in the Democratic Republic of the Congo [0.03%]
在刚果民主共和国评估糖尿病患者认知障碍的挑战
David Shamputi,Célestin Kaputu-Kalala-Malu,Bives Mutume Nzanzu Vivalya et al.
David Shamputi et al.
Dementia is a global public health issue, with 57.5 million people living with at least one type of dementia in 2019 worldwide, and projected to rise to 152 million by 2050. ...
Amado Jiménez-Ruiz,Victor Aguilar-Fuentes,Naomi Nazareth Becerra-Aguiar et al.
Amado Jiménez-Ruiz et al.
Vascular cognitive impairment (VCI) is the second most common cause of cognitive impairment after Alzheimer's disease. The VCI spectrum involves a decline in cognition attributable to vascular pathologies (e.g., large infarcts or hemorrhage...
Assessment of mental well-being and psychological distress in Moroccan breast cancer patients [0.03%]
评估摩洛哥乳腺癌患者的心理健康和心理压力
Meryam Belhaj Haddou,Hicham El Mouaddib,Zakaria Belhaj Haddou et al.
Meryam Belhaj Haddou et al.
The quality of life of breast cancer patients is strongly affected by physical pain, psychological distress, and uncertainty about vital prognosis. Objective: ...
Associations between cognitive screening performance and motor symptoms in Parkinson's disease:a systematic review and meta-analysis [0.03%]
帕金森病认知筛查与运动症状的关联：系统评价和meta分析
Karlee Patrick,Elizabeth Cousins,Mary Beth Spitznagel
Karlee Patrick
Although the most prominent symptoms of Parkinson's disease (PD) are those impacting movement, cognitive dysfunction is prevalent and often presents early in the disease process. Individuals with cognitive symptoms of PD often complete cogn...
A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer's disease [0.03%]
细胞治疗阿尔茨海默病的临床疗效和安全性的系统评价研究
Hamidreza Feizi,Mohammad-Salar Hosseini,Sepideh Seyedi-Sahebari et al.
Hamidreza Feizi et al.
There is presently no disease-modifying therapy for Alzheimer's Disease (AD), which is the most prevalent cause of dementia. Objective: This study aspires...